Nano-vesicles of Brimonidine Tartrate for Eye Treatment
Author Information
Author(s): Prabhu P, Nitish Kumar R, Koland M, Harish NM, Vijayanarayan K, Dhondge G, Charyulu RN
Primary Institution: N.G.S.M. Institute of Pharmaceutical Sciences, Paneer, Deralakatte, Mangalore, India
Hypothesis
Can nano-vesicles of brimonidine tartrate improve drug delivery and reduce dosing frequency for ocular treatment?
Conclusion
The study found that nano-vesicles of brimonidine tartrate provide a sustained intraocular pressure-lowering effect compared to the pure drug solution.
Supporting Evidence
- The vesicular formulations showed a sustained release of the drug over time.
- IOP-lowering activity was significantly better with vesicular formulations compared to pure drug solutions.
- Stability studies indicated that the formulations remained stable at 2-8°C.
Takeaway
This study shows that special tiny bubbles can help deliver eye medicine better and keep it working longer.
Methodology
Nano-vesicles were prepared using the film hydration method and evaluated for drug release and intraocular pressure-lowering activity in rabbits.
Potential Biases
Potential bias in animal model selection and treatment administration.
Limitations
The study was conducted on a small sample size and only in rabbits, which may limit generalizability to humans.
Participant Demographics
Normotensive male albino rabbits weighing 1.2-2.5 kg.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website